Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in... see more

TSXV:BTI.H - Post Discussion

biOasis Technologies Ord Shs > Bioasis marries Midatech! Same sex marriage??
View:
Post by narmac on Dec 17, 2022 6:36am

Bioasis marries Midatech! Same sex marriage??

Somewhat, but not really,,,the past history around Midatech is a true dogs breakfast,,,the only similar point is senior management types have changed like our elected representatives. I dont recall any nomes who have been long term with the company. But one point I would like to make is;

BTI shareholders have probably on average put $30 million dollars into our story since the mid teen years.
Midatech probably similar if anyone wants to check, I cant get a feel for its past market cap.

So both company shareholders have bought the techs for ruffly $60 million over the past decade!

However now,,the new shareholders seem to be buying the lions share of the tech stories in both companies for an embarrassing amount of less $$$ and what is conceived to be less risk. So how come???  Would we have no problem if the new structure came with a minimum of $30 million cash or so from these entities so the Biodexa can carry on their operations,,,, That would make things more palatable,,,,,comments???
Comment by prophetoffactz on Dec 17, 2022 8:12am
"Would we have no problem if the new structure came with a minimum of $30 million cash or so from these entities so the Biodexa can carry on their operations,,,, That would make things more palatable,,,,,comments???" The more cash the better; however in the worst biotech market in history where 25% of biotech was trading below the value of the cash on the balance sheet recently cash is ...more  
Comment by KayakerBC on Dec 17, 2022 9:34am
POOF says   "....How much can Biodexa raise through potential Neuramedy option exercise and potential deal monitization, J&J option exercise(option expires in about 30 business days), milestone payments from existing deals, and upfront from any new deals(eg. cancer or a second deal with Chiesi)? " If any of that is coming, they didn't need to sell the company. ". ...more  
Comment by fuzzyjr on Dec 17, 2022 9:53am
"do a financing at 10¢ US for 40m shares, with warrants.  That should be enough cash to wait for a partner or just do a dang Phase I study which would zoom the stock up several bucks." with all due respect kbc- not very confident about moving up several bucks with a phase when comparing to rvx & zen who are way ahead of that mark & only trading  at double the ...more  
Comment by KayakerBC on Dec 17, 2022 10:18am
with all due respect kbc- not very confident about moving up several bucks with a phase when comparing to rvx & zen who are way ahead of that mark I'm pretty confident we would.  BTI is worth billions down the road if they can just start by demonstrating safety and efficacy in a dozen patients.  I suspect investors would see the potential and the comparison to competitors.  ...more  
Comment by fuzzyjr on Dec 17, 2022 11:41am
Thanks for that explanation- makes a fella wonder why they didn't go that route or maybe they tried & no takers? a good question to have answered at the webinar.
Comment by narmac on Dec 17, 2022 10:19am
KBC,,you are spot on,,,,,I think we would be in much better shape down the road,,,,and forget the nasdaq for now,,,,if the idea is to get access to more international investors it didnt seem to work for Midatech!!!..Jmo!
Comment by prophetoffactz on Dec 17, 2022 12:16pm
"POOF says   "....How much can Biodexa raise through potential Neuramedy option exercise and potential deal monitization, J&J option exercise(option expires in about 30 business days), milestone payments from existing deals, and upfront from any new deals(eg. cancer or a second deal with Chiesi)? " If any of that is coming, they didn't need to sell the company ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities